A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2002
12/27/2002	WO2002102390A1 Enhanced drug delivery in transdermal systems
12/27/2002	WO2002102383A1 Aqueous cilostazol preparation for injection
12/27/2002	WO2002102376A1 ORALLY DELIVERABLE PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE COMPOUND HAVING AN AMINOSULFONYL GROUP (cox-2 INHIBITOR), A POLYETHYLENE GLYCOL AND A FREE-RADICAL SCAVENGING ANTIOXIDANT
12/27/2002	WO2002102357A1 A coated nicotine-containing chewing gum, manufacture and use thereof
12/27/2002	WO2002102354A1 Lymphatic drug delivery system
12/27/2002	WO2002102353A1 Process for producing stable enteric sugar-coated tablet
12/27/2002	WO2002102352A1 Composition for the treatment of diseases which affect animals' hooves
12/27/2002	WO2002102311A2 Nanoparticles for treating targeted tissues and cells
12/27/2002	WO2002102309A2 Formulation of lymphokines and method of use thereof for local or bath local and systemic control of proliferative cell disorders
12/27/2002	WO2002102305A2 Adjuvant composition for mucosal and injection delivered vaccines
12/27/2002	WO2002102304A2 Gum resin as a carrier for topical application of pharmacologically active agents
12/27/2002	WO2002102169A2 Synthetic fat composition
12/27/2002	WO2002076425A9 Manufacturing dissolvable dosage forms
12/27/2002	WO2002072072A3 Granules and granules coated with a masked taste
12/27/2002	WO2002072047A3 Cosmetic or pharmaceutical agent
12/27/2002	WO2002060454A3 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
12/27/2002	WO2002058668A3 Artificial tear composition adapted to be used with contact lenses
12/27/2002	WO2002058666A3 Process for preparing non-hygroscopic sodium valproate composition
12/27/2002	WO2002056907A3 Molecular antigen array presenting amyloid beta
12/27/2002	WO2002056831A9 Immunogenic proteoliposomes, and uses thereof
12/27/2002	WO2002055720A9 Materials and methods relating to protein aggregation in neurodegenerative disease
12/27/2002	WO2002051994A3 Polypeptides
12/27/2002	WO2002049676A3 Compositions containing inclusion complexes
12/27/2002	WO2002047664A3 Microparticles with an improved release profile and method for the production thereof
12/27/2002	WO2002045746A3 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
12/27/2002	WO2002045701A3 Crystallization inhibition of drugs in transdermal drug delivery systems
12/27/2002	WO2002045695A3 Hydrostatic delivery system for controlled delivery of agent
12/27/2002	WO2002040545A3 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point
12/27/2002	WO2002024165A3 Preparation of vitamin emulsions and concentrates thereof
12/27/2002	WO2002020610A3 Conformationally constrained labeled peptides for imaging and therapy
12/27/2002	WO2002009702A3 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
12/27/2002	WO2002005851A8 Enhancement of the action of central and peripheral nervous system agents
12/27/2002	WO2002002078A3 Improved liposomal camptothecins and uses thereof
12/27/2002	WO2001087935A9 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
12/27/2002	WO2001085141A9 β-GLUCANS ENCAPSULATED IN LIPOSOMES
12/27/2002	WO2001080865A9 Joint repair using mesenchymal stem cells
12/27/2002	WO2001078706A9 Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
12/27/2002	WO2001030336A9 Pharmaceutical formulations comprising resveratrol and use thereof
12/27/2002	CA2456864A1 Adjuvant composition for mucosal and injection delivered vaccines
12/27/2002	CA2450847A1 Novel compositions
12/27/2002	CA2450730A1 Methods for sterilizing preparations of monoclonal immunoglobulins
12/27/2002	CA2449978A1 Biofunctional fibers
12/27/2002	CA2449909A1 Male contraceptives
12/27/2002	CA2449288A1 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
12/27/2002	CA2444356A1 Orally deliverable pharmaceutical composition comprising an active compound having an aminosulfonyl group (cox-2 inhibitor), a polyethylene glycol and a free-radical scavenging antioxidant
12/27/2002	CA2443466A1 An aqueous pharmaceutical preparation of cilostazol for parenteral use
12/26/2002	US20020198567 Electro-endocytotic therapy as a treatment modality of cancer
12/26/2002	US20020198510 Method for nasal application of a medicinal substance
12/26/2002	US20020198509 Intradermal delivery of vaccines and gene therapeutic agents via microcannula
12/26/2002	US20020198412 (1R, 2S, 5R)-3-1-menthoxyalkan-1-OL cooling sensate
12/26/2002	US20020198315 Useful in the formulation of extended release pharmaceutical compositions
12/26/2002	US20020198266 Skin remedy, which allows gas transportation therethrough
12/26/2002	US20020198263 Preventing or treating deficiency by administering l-carnitine or a salt
12/26/2002	US20020198261 Liquid pharmaceutical compositions
12/26/2002	US20020198231 Compositions and methods for the treatment of Parkinson's disease
12/26/2002	US20020198209 Compositions having enhanced pharmacokinetic characteristics
12/26/2002	US20020198192 A therapeutic formulation comprising a topically acceptable non-solid vehicle and carbamazepine for treating psoriasis skin disorder; gels, creams, ointments, lotions, liquids, and suspensions
12/26/2002	US20020198186 Dissolving the peptide in acetic acid to form a solution, mixing with water, and lyophilizing; treating female infertility and for gonad protection
12/26/2002	US20020198174 Disinfecting and solubilizing steroid compositions
12/26/2002	US20020198166 Method for treatment of cancer and infectious diseases and compositions useful in same
12/26/2002	US20020198154 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
12/26/2002	US20020198141 Molecular conjugates for use in treatment of cancer
12/26/2002	US20020198136 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc.
12/26/2002	US20020198135 Compositions for release of radiosensitizers, and methods of making and using the same
12/26/2002	US20020197657 Apoptosis-related compounds and their use
12/26/2002	US20020197599 Novel adjuvants and copolymer compositions
12/26/2002	US20020197381 Caffeine complexes with enhanced taste, process for their preparation and their use
12/26/2002	US20020197337 Hypericum Perforatum L. Oleoresin, Procedure for Obtaining it and Uses of it
12/26/2002	US20020197333 DASC compositions, process for preparing same and suspensions containing same
12/26/2002	US20020197332 Treatment for ectoparasites
12/26/2002	US20020197327 Taste masked pharmaceutical compositions
12/26/2002	US20020197324 Delivery of drugs to mucosal surfaces
12/26/2002	US20020197318 Compositions
12/26/2002	US20020197312 Dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications
12/26/2002	US20020197311 Pharmaceutical preprations containing pyrogenic silicon dioxide
12/26/2002	US20020197308 Rapidly soluble drug composition
12/26/2002	US20020197306 Cationic lipid compositions targeting angiogenic endothelial cells
12/26/2002	US20020197304 Compositions for the treatment and prevention of cancer
12/26/2002	US20020197303 Microbiocide, antipyretics using flower extract
12/26/2002	US20020197300 Drug delivery system for anti-glaucomatous medication
12/26/2002	US20020197298 Interior core in well containing active materials; aperture to exterior
12/26/2002	US20020197291 Mixture of urea, hydrophilic film forming compound and water
12/26/2002	US20020197288 Topical applying; mixture of fibers and ubiquinone
12/26/2002	US20020197285 Diesters or polyesters of naphthalene dicarboxylic acid as solubilizer/stabilizer for retinoids
12/26/2002	US20020197284 Transdermal and topical administration of local anesthetic agents using basic enhancers
12/26/2002	US20020197283 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles
12/26/2002	US20020197278 Covalent coupling of botulinum toxin with polyethylene glycol
12/26/2002	US20020197271 Borellia burgdorferi epitope peptides
12/26/2002	US20020197269 Pharmaceutical composition for immunomodulation and preparation of vaccines
12/26/2002	US20020197267 Integrin binding motif containing peptides and methods of treating skeletal diseases
12/26/2002	US20020197261 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
12/26/2002	US20020197255 Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/26/2002	US20020197253 Compositions and methods for promoting or inhibiting NDPK
12/26/2002	US20020197236 Treatment of deseases by site specific instillation of cells or sitespecific transformation of cells and kits therefor
12/26/2002	US20020197231 Relaxing gelling bath compositions
12/26/2002	US20020197212 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
12/26/2002	US20020197210 Stabilized therapeutic and imaging agents
12/26/2002	US20020197209 Diagnostic imaging of lymph structures
12/26/2002	US20020197208 Low density radionuclide-containing particulate material
12/26/2002	US20020197207 Radionuclide-coated particulate material

1 ... 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 ... 1712